资源描述：
《冠状病毒Coronavirusl论文-2004 Severe Acute Respiratory Syndrome_Related Coronavirus Is Inhibited by Interferon__.pdf》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、BRIEFREPORTSevereAcuteRespiratorySyndromelishinganantiviraltreatmentforpatientswithSARS.SARSisprimarilydiagnosedbyaprocessofclinical/epidemiologicalRelatedCoronavirusIsInhibitedexclusion.Despiteimprovementintherecentpast,laboratorybyInterferon-adiagnosis,particularlymoleculardetectionofthevirusbypol
2、y-merasechainreaction,remainsunreliable,especiallyinthefirstUteStro¨her,1,2AntoninoDiCaro,4YanLi,1,2JamesE.Strong,1FredAoki,2fewdaysofthedisease;inaddition,thetestsarenotyetvali-FrankPlummer,1,2StevenM.Jones,1,3andHeinzFeldmann1,2dated.Serologicanalysisisthoughttobetheconfirmatorylab-1NationalMicrobio
3、logyLaboratory,HealthCanada,andDepartmentsoratorytest,butmostpatientswithSARSdevelopdetectableof2MedicalMicrobiologyand3Immunology,UniversityofManitoba,IgGantibodylevels34weeksaftertheonsetofsymptoms.Winnipeg,Canada;4LaboratoriodiVirologiaPadiglioneBaglivi,IstitutoNazionaleperleMalattieInfettiveL.Sp
4、allanzaniIRCCS,Rome,ItalyThus,differentialdiagnosisremainsaproblemfortheclinicianatthetimeofinitialpresentation,particularlyinindividualswithoutknownexposuretootherpatientswithSARSorhistoryCurrenttreatmentschemesforsevereacuterespiratorysyn-drome(SARS)includebroad-spectrumantibiotics,gluco-oftravelt
5、oaregionwhereSARSisendemic.corticoids,andribavirin.WeevaluatedthesusceptibilityofThecase-fatalityrateof9.5%reflects,inpart,thelackofantheSARS-relatedcoronavirus(SARSCoV)toribavirinandeffectivespecifictreatmentforthisviralinfection.Broad-spec-interferon(IFN)ainvitrobyuseofcytopathiceffect,plaquetrumant
6、ibioticstotreatcommunity-acquiredbacterialpneu-assay,andimmunoblotanalysis.Ribavirindidnotinhibitmonia,glucocorticoids,andribavirinhavebeenadministeredviralgrowthatconcentrationsattainableinhumanserum.topatientswithSARS,buttheirefficacyisunknown[35].Incontrast,IFN-ashowedaninvitroinhibitoryeffectstar
7、t-Recently,glycyrrhizinhasbeendemonstratedtoinhibittheingatconcentrationsof1000IU/mL.Inconclusion,ribavirinSARS-relatedCoV(SARSCoV)invitro[6].Ribavirinhasbeenaloneisunlikelytobebeneficialintheprophylax
